Il y a eu 50 transactions d'initiés récentes enregistrées pour Foghorn Therapeutics Inc. (FHTX), dont 34 achats et 6 ventes. Le total des achats d'initiés s'élève à $45.94M et le total des ventes d'initiés à $781.16K.
Les initiés notables ayant une activité récente comprennent Maynard Ryan D, Gottschalk Adrian, Cardama Alfonso Quintas. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — FHTX
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-02-23 |
Maynard Ryan D |
Officer |
Inconnu |
- |
- |
- |
- |
| 2026-02-23 |
Maynard Ryan D |
Chief Financial Officer |
Attribution de RSU |
400,000 |
$5.75 |
$2.3M |
400,000 |
| 2026-02-05 |
Gottschalk Adrian |
Chief Executive Officer |
Attribution de RSU |
1,075,000 |
$5.23 |
$5.62M |
1,075,000 |
| 2026-01-30 |
Cardama Alfonso Quintas |
Chief Medical Officer |
Attribution de RSU |
300,000 |
$5.71 |
$1.71M |
300,000 |
| 2026-01-30 |
Bellon Steven F. |
Chief Scientific Officer |
Attribution de RSU |
300,000 |
$5.71 |
$1.71M |
300,000 |
| 2026-01-30 |
Lacascia Michael |
Chief Legal Officer |
Attribution de RSU |
295,000 |
$5.71 |
$1.68M |
295,000 |
| 2026-01-30 |
Costa Carlos |
Chief People Officer |
Attribution de RSU |
230,000 |
$5.71 |
$1.31M |
230,000 |
| 2026-01-30 |
Rivkin Anna |
Chief Business Officer |
Attribution de RSU |
165,000 |
$5.71 |
$942.15K |
165,000 |
| 2026-01-13 |
Flagship Pioneering, Llc |
10 Percent Owner |
Attribution de RSU |
1,117,734 |
$20.13 |
$22.5M |
1,117,734 |
| 2025-11-14 |
Humer Kristian |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-06-17 |
Parshall B Lynne |
Director |
Attribution de RSU |
25,000 |
$4.79 |
$119.75K |
25,000 |
| 2025-06-17 |
Gill Simba |
Director |
Attribution de RSU |
25,000 |
$4.79 |
$119.75K |
25,000 |
| 2025-06-17 |
Smith Ian F |
Director |
Attribution de RSU |
25,000 |
$4.79 |
$119.75K |
25,000 |
| 2025-06-17 |
Lynch Thomas J. Jr. |
Director |
Attribution de RSU |
25,000 |
$4.79 |
$119.75K |
25,000 |
| 2025-06-17 |
Cole Douglas G. |
Director |
Attribution de RSU |
25,000 |
$4.79 |
$119.75K |
25,000 |
| 2025-06-17 |
Biller Scott |
Director |
Attribution de RSU |
25,000 |
$4.79 |
$119.75K |
25,000 |
| 2025-06-17 |
Mendelsohn Michael |
Director |
Attribution de RSU |
25,000 |
$4.79 |
$119.75K |
25,000 |
| 2025-05-01 |
Duty Stuart |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-05-01 |
Duty Stuart |
Director |
Attribution de RSU |
50,000 |
$4.16 |
$208K |
50,000 |
| 2025-05-01 |
Gallagher Neil |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-05-01 |
Gallagher Neil |
Director |
Attribution de RSU |
50,000 |
$4.16 |
$208K |
50,000 |
| 2025-04-25 |
Gottschalk Adrian |
Chief Executive Officer |
Don (Reçu) |
300,000 |
- |
- |
511,704 |
| 2025-04-09 |
Gottschalk Adrian |
Chief Executive Officer |
Don (Reçu) |
197,906 |
- |
- |
511,704 |
| 2025-01-22 |
Cardama Alfonso Quintas |
Chief Medical Officer |
Attribution de RSU |
125,000 |
$4.37 |
$546.25K |
125,000 |
| 2025-01-22 |
Gottschalk Adrian |
Chief Executive Officer |
Attribution de RSU |
400,000 |
$4.37 |
$1.75M |
400,000 |
| 2025-01-22 |
Bellon Steven F. |
Chief Scientific Officer |
Attribution de RSU |
140,000 |
$4.37 |
$611.8K |
140,000 |
| 2025-01-22 |
Lacascia Michael |
Chief Legal Officer |
Attribution de RSU |
126,000 |
$4.37 |
$550.62K |
126,000 |
| 2025-01-22 |
Humer Kristian |
Chief Financial Officer |
Attribution de RSU |
120,000 |
$4.37 |
$524.4K |
120,000 |
| 2025-01-22 |
Costa Carlos |
Chief People Officer |
Attribution de RSU |
115,000 |
$4.37 |
$502.55K |
115,000 |
| 2025-01-22 |
Rivkin Anna |
Chief Business Officer |
Attribution de RSU |
50,000 |
$4.37 |
$218.5K |
50,000 |
| 2024-12-29 |
Koppel Adam |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-09-23 |
Costa Carlos |
Chief People Officer |
Vente Informative |
857 |
$10.17 |
$8.72K |
- |
| 2024-09-20 |
Costa Carlos |
Chief People Officer |
Vente Informative |
35,756 |
$10.04 |
$358.99K |
- |
| 2024-09-18 |
Costa Carlos |
Chief People Officer |
Vente Informative |
11,574 |
$10.05 |
$116.32K |
- |
| 2024-09-17 |
Costa Carlos |
Chief People Officer |
Vente Informative |
10,272 |
$10.04 |
$103.13K |
- |
| 2024-09-16 |
Costa Carlos |
Chief People Officer |
Vente Informative |
400 |
$10.00 |
$4K |
- |
| 2024-09-09 |
Bellon Steven F. |
Chief Scientific Officer |
Vente Informative |
20,000 |
$9.50 |
$190K |
101,957 |
| 2024-09-03 |
Rivkin Anna |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-09-03 |
Rivkin Anna |
Chief Business Officer |
Attribution de RSU |
190,000 |
$7.85 |
$1.49M |
190,000 |
| 2024-06-26 |
Parshall B Lynne |
Director |
Attribution de RSU |
16,000 |
$5.52 |
$88.32K |
16,000 |
| 2024-06-26 |
Gill Simba |
Director |
Attribution de RSU |
16,000 |
$5.52 |
$88.32K |
16,000 |
| 2024-06-26 |
Smith Ian F |
Director |
Attribution de RSU |
16,000 |
$5.52 |
$88.32K |
16,000 |
| 2024-06-26 |
Lynch Thomas J. Jr. |
Director |
Attribution de RSU |
16,000 |
$5.52 |
$88.32K |
16,000 |
| 2024-06-26 |
Cole Douglas G. |
Director |
Attribution de RSU |
16,000 |
$5.52 |
$88.32K |
16,000 |
| 2024-06-26 |
Koppel Adam |
Director |
Attribution de RSU |
16,000 |
$5.52 |
$88.32K |
16,000 |
| 2024-06-26 |
Biller Scott |
Director |
Attribution de RSU |
16,000 |
$5.52 |
$88.32K |
16,000 |
| 2024-06-26 |
Mendelsohn Michael |
Director |
Attribution de RSU |
16,000 |
$5.52 |
$88.32K |
16,000 |
| 2024-06-21 |
Cavalie Fanny |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-05-22 |
Flagship Pioneering Inc. |
10 Percent Owner |
Achat Informatif |
1,814,914 |
$0.00 |
$181.49 |
1,814,914 |
| 2024-05-22 |
Flagship Pioneering Fund Vii General Partner Llc |
10 Percent Owner |
Inconnu |
1,814,915 |
$0.00 |
$181.49 |
- |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
